Hydrochloric Acid → HCID 71737241, compound

HRID 717086Notes

Reaction equation

HRID 717086 reaction equation
C([Si](C1C=CC=CC=1)(C1C=CC=CC=1)[O:6][CH:7]1[CH2:12][CH2:11][N:10]([CH2:13][C:14]2[CH:19]=[CH:18][C:17]([C:20]3[NH:21][C:22](=[O:31])[C:23]4[C:28]([CH:29]=3)=[C:27]([CH3:30])[CH:26]=[CH:25][CH:24]=4)=[CH:16][CH:15]=2)[CH2:9][CH2:8]1)(C)(C)C.Cl>C(Cl)Cl>[OH:6][CH:7]1[CH2:12][CH2:11][N:10]([CH2:13][C:14]2[CH:19]=[CH:18][C:17]([C:20]3[NH:21][C:22](=[O:31])[C:23]4[C:28]([CH:29]=3)=[C:27]([CH3:30])[CH:26]=[CH:25][CH:24]=4)=[CH:16][CH:15]=2)[CH2:9][CH2:8]1

Participants

4

Procedure

To a stirred solution of 3-{4-[4-(tert-butyl-diphenyl-silanyloxy)-piperidin-1-ylmethyl]-phenyl}-5-methyl-2H-isoquinolin-1-one (213 mg, 0.36 mmol) in CH2Cl2 (2 mL) was added 1.25M methanolic HCl (1 mL) and the reaction stirred at RT for 48 h. The reaction mixture was concentrated in vacuo and the crude residue purified by reverse phase preparative HPLC-MS to afford 3-[4-(4-hydroxy-piperidin-1-ylmethyl)-phenyl]-5-methyl-2H-isoquinolin-1-one as a pale yellow solid (80 mg, 64%).

Workup

  1. concentrationThe reaction mixture was concentrated in vacuo
  2. customthe crude residue purified by reverse phase preparative HPLC-MS

Sources & evidence

ORD record
ord-05583d8afb4f4aedbee143c8bf8ce6c0
Source dataset
uspto-grants-2015_11
Patent number
US09193689B2

Reaction notes

Loading…